The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. Keeping that in mind, here are two stocks we think live up to the hype and one best left ignored.
One Stock to Sell:
United Community Banks (UCB)
One-Month Return: -0.7%
Starting as a small community bank in 1950 and expanding through strategic acquisitions across the Southeast, United Community Banks (NYSE:UCB) is a regional bank holding company that provides financial services including loans, deposits, wealth management, and merchant services across the southeastern United States.
Why Are We Wary of UCB?
- Annual revenue growth of 8% over the last two years was below our standards for the banking sector
- Estimated net interest income growth of 2.1% for the next 12 months implies demand will slow from its five-year trend
- Incremental sales over the last five years were less profitable as its earnings per share were flat while its revenue grew
United Community Banks is trading at $35.76 per share, or 1.1x forward P/B. To fully understand why you should be careful with UCB, check out our full research report (it’s free).
Two Stocks to Watch:
Interface (TILE)
One-Month Return: +22.8%
Pioneering carbon-neutral flooring since its founding in 1973, Interface (NASDAQ:TILE) is a global manufacturer of modular carpet tiles, luxury vinyl tile (LVT), and rubber flooring that specializes in carbon-neutral and sustainable flooring solutions.
Why Are We Fans of TILE?
- Performance over the past two years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 34.1% outpaced its revenue gains
- Free cash flow margin increased by 7.5 percentage points over the last five years, giving the company more capital to invest or return to shareholders
- Returns on capital are growing as management capitalizes on its market opportunities
At $39.35 per share, Interface trades at 1.6x trailing 12-month price-to-sales. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Amgen (AMGN)
One-Month Return: +21.2%
Founded in 1980 during the early days of the biotechnology revolution, Amgen (NASDAQ:AMGN) is a biotechnology company that discovers, develops, and manufactures innovative medicines to treat serious illnesses like cancer, osteoporosis, and autoimmune diseases.
Why Does AMGN Stand Out?
- Economies of scale give it more fixed cost leverage than its smaller competitors
- Strong free cash flow margin of 28.2% enables it to reinvest or return capital consistently
- ROIC punches in at 17.3%, illustrating management’s expertise in identifying profitable investments
Amgen’s stock price of $441.50 implies a valuation ratio of 18.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
